ELRIG’s annual Drug Discovery meeting is returning this October, giving us an excellent chance to re-connect with colleagues and discuss the future of drug discovery. The meeting is titled ‘After the Storm: Re-Connect, Re-Invent, Re-Imagine’ and looks to celebrate the scientific progress and successes during the pandemic.
TherapeutAix will be in attendance on Tuesday 19th October – Wednesday 20th October at The Exhibition Centre, ACC, Liverpool.
This year Bob Humphries from TherapeutAix will be presenting a poster that encapsulates thoughts on inhaled delivery titled ‘Inhalation: The Inspired Choice in the Treatment of Respiratory Disease’. The poster covers a range of topics including the perception and reality of inhaled delivery, and whether there are missed opportunities in the use of inhaled delivery in the prevention/early treatment of Covid-19 and in the treatment of IPF. You can read in detail about our work in inhalation in our four-part blog series here:
- Targeted Delivery in IPF: Inhalation Therapy
- Challenges in inhaled drug therapy
- Targeting Drug Effects in IPF: Part 1
- Pitfalls with Oral Drug Administration in IPF
To find out more about the event and register, click here.
